 |
Code of Federal Regulations (Last Updated: April 5, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter E - Animal Drugs, Feeds, and Related Products |
|
|
Part 524 - Ophthalmic and Topical Dosage Form New Animal Drugs |
| § 524.86 - Amitraz. |
| § 524.154 - Bacitracin, neomycin, and polymyxin B ophthalmic ointment. |
| § 524.155 - Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment. |
| § 524.230 - Buprenorphine. |
| § 524.321 - Cephalonium, polymyxin B sulfate, flumethasone, iodochlorhy-droxyquin, piperocaine hydrochloride topical-otic ointment. |
| § 524.390 - Chloramphenicol ophthalmic ointment. |
| § 524.402 - Chlorhexidine. |
| § 524.450 - Clotrimazole. |
| § 524.463 - Copper naphthenate. |
| § 524.520 - Cuprimyxin cream. |
| § 524.575 - Cyclosporine ophthalmic ointment. |
| § 524.590 - Diclofenac. |
| § 524.660 - Dimethyl sulfoxide. |
| § 524.770 - Doramectin. |
| § 524.775 - Emodepside and praziquantel. |
| § 524.802 - Enrofloxacin and silver sulfadiazine otic emulsion. |
| § 524.814 - Eprinomectin. |
| § 524.815 - Eprinomectin and praziquantel. |
| § 524.838 - Esafoxolaner, eprinomectin, and praziquantel. |
| § 524.900 - Famphur. |
| § 524.916 - Fentanyl. |
| § 524.920 - Fenthion. |
| § 524.955 - Florfenicol, terbinafine, and betamethasone acetate otic gel. |
| § 524.957 - Florfenicol, terbinafine, and mometasone otic solution. |
| § 524.960 - Flumethasone, neomycin, and polymyxin B ophthalmic solution. |
| § 524.970 - Flunixin. |
| § 524.1451 - Moxidectin. |
| § 524.1880 - Prednisolone-neomycin sulfate ophthalmic ointment. |
| § 524.1881 - Prednisolone acetate ophthalmic and topical dosage forms. |
| § 524.1883 - Prednisolone sodium phosphate-neomycin sulfate ophthalmic ointment. |
| § 524.2140 - Squalane, pyrethrins and piperonyl butoxide. |
| § 524.2481 - Triamcinolone cream. |
| § 524.2640 - Tylosin, neomycin eye powder. |
| § 524.390a - Chloramphenicol ophthalmic ointment. |
| § 524.660a - Dimethyl sulfoxide solution. |
| § 524.390b - Chloramphenicol ophthalmic solution. |
| § 524.660b - Dimethyl sulfoxide gel. |
| § 524.390c - Chloramphenicol-prednisolone-tetracaine-squalane topical suspension. |
| § 524.390d - Chloramphenicol-prednisolone ophthalmic ointment. |
| § 524.1580d - [Reserved] |
| § 524.1580e - Nitrofurazone ointment with butacaine sulfate. |
| Fluocinolone Topical and Otic Dosage Forms |
| § 524.981 - [Reserved] |
| § 524.998 - Fluralaner. |
| § 524.1001 - Fluralaner and moxidectin. |
| § 524.1005 - Furazolidone powder. |
| § 524.1044 - Gentamicin ophthalmic and topical dosage forms. |
| § 524.1132 - Hydrocortisone, miconazole, and gentamicin otic suspension. |
| § 524.1140 - Imidacloprid and ivermectin. |
| § 524.1146 - Imidacloprid and moxidectin. |
| § 524.1193 - Ivermectin topical solution. |
| § 524.1195 - Ivermectin otic suspension. |
| § 524.1200 - Kanamycin ophthalmic and topical dosage forms. |
| § 524.1204 - Kanamycin, amphomycin, and hydrocortisone ointment. |
| § 524.1240 - Levamisole. |
| § 524.1376 - 2-Mercaptobenzothiazole solution. |
| § 524.1443 - Miconazole. |
| § 524.1445 - Miconazole, polymixin B, and prednisolone suspension. |
| § 524.1446 - Milbemycin otic solution. |
| § 524.1448 - Mirtazapine transdermal ointment. |
| § 524.1450 - Moxidectin. |
| § 524.1465 - Mupirocin. |
| § 524.1484 - Neomycin ophthalmic and topical dosage forms. |
| § 524.1580 - Nitrofurazone topical dosage forms. |
| § 524.1600 - Nystatin ophthalmic and topical dosage forms. |
| § 524.1610 - Orbifloxacin, mometasone furoate monohydrate, and posaconazole suspension. |
| § 524.1662 - Oxytetracycline ophthalmic and topical dosage forms. |
| § 524.1742 - Phosmet emulsifiable liquid. |
| § 524.1982 - Proparacaine ophthalmic solution. |
| § 524.2080 - Ropinirole. |
| § 524.2098 - Selamectin. |
| § 524.2099 - Selamectin and sarolaner. |
| § 524.2101 - Selenium disulfide suspension. |
| § 524.2350 - Tolnaftate cream. |
| § 524.2482 - Triamcinolone spray. |
| § 524.2483 - Triamcinolone cream. |
| § 524.2620 - Liquid crystalline trypsin, Peru balsam, castor oil. |
| § 524.1200a - Kanamycin ophthalmic ointment. |
| § 524.1580a - Nitrofurazone ointment. |
| § 524.1600a - Nystatin, neomycin, thiostrepton, and triamcinolone ointment. |
| § 524.1200b - Kanamycin ophthalmic solution. |
| § 524.1580b - Nitrofurazone soluble powder. |
| § 524.1600b - Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment. |
| § 524.1580c - Nitrofurazone and butacaine ointment. |
| § 524.981a - Fluocinolone cream. |
| § 524.981b - Fluocinolone solution. |
| § 524.981c - Fluocinolone and neomycin cream. |
| § 524.981d - Fluocinolone and dimethyl sulfoxide solution. |
| § 524.981e - Fluocinolone and dimethyl sulfoxide otic solution. |
| § 524.1662a - Oxytetracycline and hydrocortisone spray. |
| § 524.1662b - Oxytetracycline and polymyxin B ophthalmic ointment. |
| § 524.1044a - Gentamicin ophthalmic solution. |
| § 524.1044b - Gentamicin and betamethasone otic solution. |
| § 524.1484b - Neomycin, isoflupredone, and tetracaine powder. |
| § 524.1044c - Gentamicin ophthalmic ointment. |
| § 524.1484c - Neomycin, isoflupredone, and tetracaine ointment. |
| § 524.1044d - Gentamicin and betamethasone ointment. |
| § 524.1484d - Neomycin, hydrocortisone, and tetracaine otic ointment. |
| § 524.1044e - Gentamicin spray. |
| § 524.1484e - Neomycin and polymyxin B ophthalmic solution. |
| § 524.1044f - Gentamicin and betamethasone spray. |
| § 524.1484f - Neomycin, prednisolone, and tetracaine otic suspension. |
| § 524.1044g - Gentamicin, betamethasone, and clotrimazole ointment. |
| § 524.1484g - Neomycin, thiabendazole, and dexamethasone solution. |
| § 524.1044h - Gentamicin, mometasone, and clotrimazole otic suspension. |
| § 524.1484h - Neomycin, penicillin, polymyxin B, and hydrocortisone suspension. |
| § 524.1044i - Gentamicin and betamethasone ophthalmic solution. |
| § 524.1484i - Neomycin and hydrocortisone ointment. |
| § 524.1484j - Neomycin and prednisolone ophthalmic ointment. |
| § 524.1484k - Neomycin and prednisolone suspension. |
| § 524.1881a - [Reserved] |
| § 524.1881b - Prednisolone acetate-neomycin sulfate sterile suspension. |
| § 524.1484a - Neomycin sulfate ophthalmic ointment. |